(Headquarters: Tokyo; CEO: Haruo Naito) announced that its in-house developed dual orexin receptor antagonist, DAYVIGO® (brand name in China: 达卫可®, generic name: lemborexant), has been approved in China for the…
AstraZeneca Showcases Oncology Breakthroughs at ASCO 2025, Reinforcing Mission to Eliminate Cancer as a Cause of Death AstraZeneca will present new data from over 80 abstracts at the 2025 American…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a significant legal victory after a jury in the U.S. District Court for the District of Delaware ruled that Amgen Inc. violated multiple antitrust…
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today reported that its Phase 3 KEYNOTE-B96 trial (ENGOT-ov65) has met its primary endpoint, showing a statistically significant…
Shockwave Medical, Inc., now part of Johnson & Johnson MedTech and a global leader in circulatory restoration, announced today that it will showcase data from 23 company-sponsored studies—including three late-breaking…
McKesson Reports Strong Q4 and FY2025 Financial Results, Issues Robust FY2026 Guidance, and Announces Intent to Spin Off Medical-Surgical Solutions Segment McKesson Corporation (NYSE: MCK) has reported impressive financial results…
Sangamo Therapeutics to Release First Quarter 2025 Financial Results and Host Earnings Conference Call on May 12 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a clinical-stage genomic medicine company developing transformative therapies…
Pacific Prime Thailand Honored with AXA Thailand’s 2025 Top International Broker Award In a significant recognition of its dedication to excellence and commitment to strategic partnerships, Pacific Prime Thailand has…
UnitedHealthcare Community Plan of Arizona Selected to Continue Statewide Service for Long-Term Care Members Under ALTCS EPD Program The Arizona Health Care Cost Containment System (AHCCCS), the state’s Medicaid agency,…
Arizona Complete Health Joins Settlement Agreement to Advance Statewide ALTCS Medicaid Contract Centene Corporation (NYSE: CNC), a Fortune 50 healthcare enterprise dedicated to transforming the health of the communities it…
Viridian Therapeutics Announces Inducement Equity Grants for New Hires in Accordance with Nasdaq Rule 5635(c)(4) Viridian Therapeutics, Inc. (Nasdaq: VRDN), a clinical-stage biopharmaceutical company dedicated to advancing innovative therapies for…
University of Phoenix and NCH Healthcare Partner to Deliver Education and Tuition Benefits for Workforce Development In a strategic move to enhance workforce development and support the professional growth of…